Total planned funding: $1,468,116,866
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $234,640,583 |
Zambia | $176,234,996 |
Tanzania | $172,201,383 |
Mozambique | $115,985,347 |
Ethiopia | $106,892,431 |
Kenya | $106,823,718 |
Uganda | $95,778,364 |
Côte d'Ivoire | $89,636,600 |
South Africa | $70,364,081 |
Zimbabwe | $65,177,913 |
Rwanda | $50,915,920 |
Haiti | $40,845,728 |
Vietnam | $21,774,242 |
Botswana | $19,667,027 |
Namibia | $19,629,626 |
Eswatini | $10,566,400 |
Indonesia | $10,189,178 |
Burundi | $7,795,295 |
Malawi | $7,700,800 |
Central America Region | $6,547,996 |
Democratic Republic of the Congo | $5,345,438 |
Ghana | $4,820,332 |
Guyana | $4,808,322 |
Caribbean Region | $4,696,781 |
Ukraine | $4,300,000 |
Dominican Republic | $3,718,236 |
Lesotho | $2,250,000 |
Central Asia Region | $2,232,129 |
South Sudan | $1,674,000 |
Cameroon | $1,200,000 |
Cambodia | $1,150,000 |
Angola | $1,034,000 |
Russia | $770,000 |
India | $750,000 |
Organizational Types
Private Contractor | $1,468,116,866 |
Program Areas
Treatment | $689,766,812 |
Governance and Systems | $300,267,978 |
Prevention | $208,956,874 |
Care | $203,997,076 |
Testing | $61,624,040 |
Budget Codes
HTXD: Treatment: ARV Drugs | $540,493,927 |
OHSS: Health Systems Strengthening | $144,186,469 |
HTXS: Treatment: Adult Treatment | $132,851,171 |
HLAB: Laboratory Infrastructure | $109,670,496 |
HBHC: Care: Adult Care and Support | $105,136,792 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $85,228,317 |
HVCT: Testing: HIV Testing and Counseling | $61,624,040 |
HKID: Care: Orphans and Vulnerable Children | $57,993,964 |
HVSI: Strategic Information | $46,411,013 |
HVOP: Sexual Prevention: Other Sexual Prevention | $41,922,370 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $37,507,012 |
HVTB: Care: TB/HIV | $31,022,961 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $19,864,428 |
PDTX: Treatment: Pediatric Treatment | $16,421,714 |
HMIN: Biomedical Prevention: Injection Safety | $12,191,649 |
PDCS: Care: Pediatric Care and Support | $9,843,359 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,556,859 |
HMBL: Biomedical Prevention: Blood Safety | $3,686,239 |
Top Partner Programs
Deloitte Consulting Limited:
$55,517,562
View countries